EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

MRAS in coronary artery disease—Unchartered territory

Pashmina Wiqar Shah, Tobias Reinberger, Satwat Hashmi, Zouhair Aherrahrou iD, Jeanette Erdmann iD

IUBMB Life · 2024

DOI: 10.1002/iub.2805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift IUBMB Life, 2024. Verfasst von Pashmina Wiqar Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiogenetics, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Coronary Artery Disease, Genome-Wide Association Study. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Fondation Leducq, DZHK/BHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome‐wide association studies (GWAS) have identified coronary artery disease (CAD) susceptibility locus on chromosome 3q22.3. This locus contains a cluster of several genes that includes muscle rat sarcoma virus ( MRAS ). Common MRAS variants are also associated with CAD causing risk factors such as hypertension, dyslipidemia, obesity, and type II diabetes. The MRAS gene is an oncogene that encodes a membrane‐bound small GTPase. It is involved in a variety of signaling pathways, regulating cell differentiation and cell survival (mitogen‐activated protein kinase [MAPK]/extracellular signal‐regulated kinase and phosphatidylinositol 3‐kinase) as well as acute phase response signaling (tumor necrosis factor [TNF] and interleukin 6 [IL6] signaling). In this review, we will summarize the role of genetic MRAS variants in the etiology of CAD and its comorbidities with the focus on tissue distribution of MRAS isoforms, cell type/tissue specificity, and mode of action of single nucleotide variants in MRAS associated complex traits. Finally, we postulate that CAD risk variants in the MRAS locus are specific to smooth muscle cells and lead to higher levels of MRAS , particularly in arterial and cardiac tissue, resulting in MAPK‐dependent tissue hypertrophy or hyperplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseGenome-Wide Association StudyHumansGenetic Predisposition to DiseasePolymorphism, Single NucleotideAnimalsSignal Transductionras Proteins

Stichwörter der Autor:innen

GWASMRASSNVsatherosclerosiscoronary artery disease

Substanzen

MRAS protein, humanras Proteins

Autor:innen und Institutionen

  • Institute for Cardiogenetics, University of Lübeck, Lübeck, Germany.
  • DZHK (German Research Centre for Cardiovascular Research), Lübeck, Germany.
  • University Heart Center Lübeck, Lübeck, Germany.
  • Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.

ORCID-Profile: Zouhair Aherrahrou, Jeanette Erdmann

Förderung

  • Deutsche Forschungsgemeinschaft
  • Fondation Leducq
  • DZHK/BHF
  • DAAD (Deutscher Akademischer Austauschdienst)
  • Deutscher Akademischer Austauschdienst

Zitieren

APA

Shah, P. W., Reinberger, T., Hashmi, S., Aherrahrou, Z., & Erdmann, J. (2024). MRAS in coronary artery disease—Unchartered territory. IUBMB Life. https://doi.org/10.1002/iub.2805

Vancouver

Shah PW, Reinberger T, Hashmi S, Aherrahrou Z, Erdmann J. MRAS in coronary artery disease—Unchartered territory. IUBMB Life. 2024. doi:10.1002/iub.2805

BibTeX
@article{Shah2024,
  author = {Shah, Pashmina Wiqar and Reinberger, Tobias and Hashmi, Satwat and Aherrahrou, Zouhair and Erdmann, Jeanette},
  title = {MRAS in coronary artery disease—Unchartered territory},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2805}
}
Kostenlos starten →